Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Grimm

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Transplantation|September 11, 2012
Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipientsLieuko Nguyen, Robert B McClellan, Abanti Chaudhuri, et al.
Kidney International|May 20, 2003
Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shorteningAnette Melk, Wipawee Kittikowit, Irwindeep Sandhu, et al.
Kidney International|December 1, 2005
Transcriptional analysis of the molecular basis of human kidney aging using cDNA microarray profilingAnette Melk, Elaine S Mansfield, Szu-Chuan Hsieh, et al.
Pediatrics|January 26, 2026
Trends in End-Stage Kidney Disease Due to Reflux Nephropathy in Children and Young AdultsAlexander J Wolf, Sai Liu, Margaret Stedman, et al.
Pediatric Transplantation|May 10, 2008
Multicenter trial of everolimus in pediatric renal transplant recipients: results at three yearRobert Ettenger, Peter-Friedrich Hoyer, Paul Grimm, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 5, 2012
A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safetyCraig B Langman, Larry A Greenbaum, Minnie Sarwal, et al.
Pediatric Transplantation|August 8, 2022
Malnutrition and immune cell subsets in children undergoing kidney transplantationBrian I Shaw, Hui-Jie Lee, Robert Ettenger, et al.
The Journal of Pediatrics|June 21, 2014
Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrateCraig B Langman, Larry A Greenbaum, Paul Grimm, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 22, 2021
Relationship between antithymocyte globulin, T cell phenotypes, and clinical outcomes in pediatric kidney transplantationBrian I Shaw, Hui-Jie Lee, Cliburn Chan, et al.
Journal of the American Society of Nephrology : JASN|March 1, 2011
Screening for NPHS2 mutations may help predict FSGS recurrence after transplantationTherese C Jungraithmayr, Katrin Hofer, Pierre Cochat, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Transplantation|September 11, 2012
Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipientsLieuko Nguyen, Robert B McClellan, Abanti Chaudhuri, et al.
Kidney International|May 20, 2003
Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shorteningAnette Melk, Wipawee Kittikowit, Irwindeep Sandhu, et al.
Kidney International|December 1, 2005
Transcriptional analysis of the molecular basis of human kidney aging using cDNA microarray profilingAnette Melk, Elaine S Mansfield, Szu-Chuan Hsieh, et al.
Pediatrics|January 26, 2026
Trends in End-Stage Kidney Disease Due to Reflux Nephropathy in Children and Young AdultsAlexander J Wolf, Sai Liu, Margaret Stedman, et al.
Pediatric Transplantation|May 10, 2008
Multicenter trial of everolimus in pediatric renal transplant recipients: results at three yearRobert Ettenger, Peter-Friedrich Hoyer, Paul Grimm, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 5, 2012
A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safetyCraig B Langman, Larry A Greenbaum, Minnie Sarwal, et al.
Pediatric Transplantation|August 8, 2022
Malnutrition and immune cell subsets in children undergoing kidney transplantationBrian I Shaw, Hui-Jie Lee, Robert Ettenger, et al.
The Journal of Pediatrics|June 21, 2014
Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrateCraig B Langman, Larry A Greenbaum, Paul Grimm, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 22, 2021
Relationship between antithymocyte globulin, T cell phenotypes, and clinical outcomes in pediatric kidney transplantationBrian I Shaw, Hui-Jie Lee, Cliburn Chan, et al.
Journal of the American Society of Nephrology : JASN|March 1, 2011
Screening for NPHS2 mutations may help predict FSGS recurrence after transplantationTherese C Jungraithmayr, Katrin Hofer, Pierre Cochat, et al.
Pageof 3